New study reveals promising therapy that blocks microRNAs to treat myotonic dystrophy type 1
A team of researchers has identified a promising therapy based on antimiRs to treat myotonic dystrophy type 1 (DM1), a complex genetic disorder caused by an abnormally high number of…